All AbMole products are for research use only, cannot be used for human consumption.
Vanoxerine dihydrochloride (GBR-12909 dihydrochloride) is a piperazine derivative which is a potent and selective DRI (dopamine reuptake inhibitor). GBR-12909 binds to the target site on the DAT ~ 500 times more strongly than cocaine, but simultaneously inhibits the release of dopamine. This combined effect only slightly elevates dopamine levels, giving vanoxerine only mild stimulant effects. Vanoxerine has been researched for use in treating cocaine dependence both as a substitute for cocaine and to block the rewarding effects.
| Molecular Weight | 523.49 |
| Formula | C28H32F2N2O.2HCl |
| CAS Number | 67469-78-7 |
| Solubility (25°C) | DMSO 8 mg/mL |
| Storage | 4°C, dry, sealed |
[4] Antonio E Lacerda, et al. Vanoxerine: cellular mechanism of a new antiarrhythmic
| Related Dopamine Receptor Products |
|---|
| AJ-76
AJ-76 ((+)-AJ 76; (1S,2R)-AJ 76) is a dopamine autoreceptor antagonist. |
| A-412997
A-412997 is a selective Dopamine D4 agonist with Ki values of 12 and 7.9 nM for the rat and human receptors. |
| SKF 81297
SKF 81297 is a potent and selective dopamine D1 receptor agonist. |
| GBR 12783
GBR 12783 is a specific, potent and selective dopamine uptake inhibitor that inhibits the [3H]dopamine uptake by rat and mice striatal synaptosomes with IC50s of 1.8 nM and 1.2 nM, respectively. |
| RMI-61140
RMI-61140 is an orally active neuroleptics. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
